This application is a U.S. National Stage Application filed under 35 U.S.C. § 371(a) which claims the benefit of and priority to International Patent Application Serial No. PCT/CN2017/078142, filed Mar. 24, 2017, the entire disclosure of which is incorporated by reference herein.
The present disclosure relates to endosurgical devices, systems and methods for observing internal features of a body during minimally invasive surgical procedures, and more particularly, to endoscopes including a therapeutic unit and methods of using endoscopes to treat tissue.
Endoscopes are introduced through an incision or a natural body orifice to observe internal features of a body. Conventional endoscopes are typically used for visualization during endoscopic or laparoscopic surgical procedures. During such surgical procedures, it is common for tissue to be bluntly or sharply dissected, ligated, and/or sealed. Infections or the like may occur after such surgical procedures due in part to the disruption of tissue.
To help minimize the effects of such infections or the like, postoperative procedures are typically performed. However, postoperative procedures use additional instruments, take additional time, and are thus costly. Accordingly, it may be beneficial to provide an endoscope that can both provide visualization of tissue and provide therapeutic functions to tissue.
The present disclosure relates to an endoscope including a handle, an elongated body extending distally from the handle and defining a longitudinal axis, a light source disposed within the distal portion of the elongated body and configured to illuminate tissue, and a therapeutic unit disposed within the distal portion of the elongated body and configured to treat tissue.
In disclosed embodiments, the therapeutic unit includes a plurality of LED elements. It is further disclosed that the endoscope includes a controller disposed in electrical communication with the light source and with the therapeutic unit. It is also disclosed that the endoscope includes an image sensor disposed within the distal portion of the elongated body and configured to capture a plurality of images.
According to aspects of the present disclosure, the therapeutic unit produces light energy. It is disclosed that the therapeutic unit is configured to focus the light energy on an area of tissue that is smaller than an area of tissue illuminated by the light source. It is further disclosed that the therapeutic unit includes a light emitting element and a lens. In embodiments, the lens includes a proximal surface and a distal surface. The proximal surface is disposed at first angle with respect to a first axis, and the distal surface disposed at a second angle with respect to the second axis. The first angle is between about 5° and about 15°, the second angle is between about 5° and about 15°, and the first axis is perpendicular to the longitudinal axis.
In disclosed embodiments, the therapeutic unit is configured to emit light having a wavelength raging from about 500 nm to about 650 nm. In embodiments, the therapeutic unit includes one red light, one blue light and one green light.
The present disclosure also relates to a method of treating tissue including positioning an endoscope adjacent tissue, illuminating the tissue using a light source of the endoscope, and treating the tissue using a therapeutic unit of the endoscope.
In disclosed embodiments of the method, illuminating the tissue using the light source includes illuminating a first area of tissue. Additionally, treating the tissue using the therapeutic unit includes focusing light energy on a second area of tissue. The second area of tissue is smaller than the first area of tissue.
In further disclosed embodiments of the method, treating the tissue using the therapeutic unit includes emitting light having a wavelength raging from about 500 nm to about 600 nm from the therapeutic unit to, for example, coagulate blood within the tissue, emitting light having a wavelength of about 570 nm from the therapeutic unit to induce fresh blood cells in the tissue to, for example, produce fluorescence, or emitting light having a wavelength of about 650 nm from the therapeutic unit to, for example, kill gangrene cells within the tissue.
Further details and aspects of various embodiments of the present disclosure are described in more detail below with reference to the appended figures.
Embodiments of the present disclosure are described herein with reference to the accompanying drawings, wherein:
Embodiments of the presently disclosed endoscopes and methods of treatment are described in detail with reference to the drawings, in which like reference numerals designate identical or corresponding elements in each of the several views. As used herein, the term “distal” refers to that portion of a structure that is farther from a user, while the term “proximal” refers to that portion of a structure that is closer to the user. The term “clinician” refers to a doctor, nurse, or other care provider and may include support personnel. The term “about” shall be understood as a word of approximation that takes into account relatively little to no variation in a modified term (e.g., differing by less than 2%).
Referring initially to
The video system 30 is operatively connected to an image sensor 32 mounted to, or disposed within, the handle 18 of the endoscope 10 via a data cable 34. An objective lens 36 is disposed at the distal end 14 of the elongated body 12 of the endoscope 10 and a series of spaced-apart, relay lenses 38, such as rod lenses, are positioned along the length of the elongated body 12 between the objective lens 36 and the image sensor 32. Images captured by the objective lens 36 are forwarded through the elongated body 12 of the endoscope 10 via the relay lenses 38 to the image sensor 32, which are then communicated to the video system 30 for processing and output to the display device 40 via cable 39.
The image sensor 32 is located within, or mounted to, the handle 18 of the endoscope 10, which can be up to about 30 cm away from the distal end 14 of the endoscope 10. Due to this relatively long distance, there is loss of image information in the image retrieval pathway as it is difficult to get a high quality image at every point along the whole working distance of the relay lenses 38. Moreover, due to light loss on the relay lenses 38, the objective lens 36 cannot include a small aperture. Therefore, the depth of field is limited and a focusing module (not shown) is typically utilized in the endocoupler 16 to set the objective lens 36 to a desired focal point, which a clinician adjusts when moving the endoscope 10 during a surgical procedure. Also, rotation of the fiber guide 22 will also rotate the relay lenses 38, which changes the viewing angle during use, and the fiber guide 22 also tends to fall due to the force of gravity. Accordingly, a clinician needs to adjust and/or hold the fiber guide 22 during use to keep the view stable, which is inconvenient during operation.
As shown in
Referring now to
The endoscope 110 includes a handle 112 and an elongated body 114 having a cylindrical wall 114a extending distally from the handle 112 and defines a longitudinal axis “x.” The elongated body 114 includes a distal portion 116 terminating at a distal end or tip 118. The handle 112 includes a handle housing 112a including a grip portion 113 for handling by a clinician and a control portion 115 including actuating elements 115a (e.g., buttons, switches etc.) for functional control of the endoscope 110.
With reference to
As the image retrieval pathway is shortened over that of traditional endoscope systems (e.g.,
The light source 150 is disposed at the distal end 118 of the endoscope 110. Light source 150 includes one or more high efficiency light emitting elements 152, such as light-emitting diodes (LED) arranged in an annular ring around the lens 144 to ensure adequate and even light distribution. In embodiments, the light emitting elements 152 have a luminous efficacy of up to about 80 lm/W (lumen/watt). As compared to traditional endoscopes, the light source of the present disclosure reduces or eliminates the need for the use of an external light source and fiber guide, which can lower the cost of the endoscope system, simplify the endoscope system structure, and reduce light consumption and/or light distortion during light transmission. Although light emitting elements 152 may be efficient and produce less heat than other types of lighting, light emitting elements 152 still produce some heat, which can degrade the quality of the image, for instance.
Various endoscopes and methods to manage, reduce and/or dissipate the heat output from the light source are disclosed in corresponding International Patent Application Serial No. PCT/CN2017/078143, filed on Mar. 24, 2017, the entire contents of which are incorporated by reference herein. Other endoscopes that include a passive thermal control system are disclosed in U.S. Patent Application Publication No. 2016/0007833, filed on Jun. 3, 2015, the entire contents of which being incorporated by reference herein.
With particular reference to
Endoscope 1110 is shown in
In the embodiment illustrated in
With particular reference to
In embodiments, a processor 1155 is engaged with or connected to light source 1150 and therapeutic unit 1160, and is in electrical communication with a controller 1170 disposed within handle 1120.
In embodiments where endoscope 1110 includes controller 1170, controller 1170 is electrically connected to sensor substrate 1180 and light source substrate 1190 via cables, for example. The engagement between sensor substrate 1180 and image sensor 1142 results in an electrical connection between controller 1170 and image sensor 1142, and the engagement between light source substrate 1190 and light source 1150 and therapeutic unit 1160 results in an electrical connection between controller 1170, light source 1150 and therapeutic unit 1160.
With particular reference to
In particular, to help focus the light toward a particular point, a first or proximal surface 1164a of the lens 1164 is disposed at first angle α1 with respect to a first axis “A” which is perpendicular to the optical axis “0,” and a second or distal surface 1164b of the lens 1164 is disposed at a second angle α2 with respect to the first axis “A.” In disclosed embodiments, each of the first angle α1 and the second angle α2 is between about 5° and about 15° (approximately equal to about 10°). It is envisioned that the first angle α1 and the second angle α2 are functions of the distance of LED light emitting element (e.g., 1160) from the optical axis “0.” That is, the first angle α1 and the second angle α2 are larger as the distance from the optical axis “0” increases. It is also envisioned that the first angle α1 and the second angle α2 are the same value or different values.
One disclosed way of determining the shape of the lens 1164 is schematically illustrated in
Endoscope 1110 is configured to illuminate tissue, help a clinician view tissue, and/or to provide therapeutic treatment to tissue. When in use or open, therapeutic unit 1160 is configured to focus it light energy on a small area of tissue (relative to the amount of tissue that is illuminated by light source 1150). The tissue that is focused on absorbs the light energy from the therapeutic unit 1160 and thus increases in temperature. As the temperature of this tissue increases, some of the components of the tissue, such as protein, are broken down, which can have healing effects.
Since different parts of tissue have different absorption rates with respect to different wavelengths of lights, therapeutic unit 1160 can be controlled to produce light within various wavelengths for different healing effects. For example, when at least one LED light emitting element 1160a-1160c of therapeutic unit 1160 emits light with a wavelength raging from about 500 nm to about 600 nm, the blood within the tissue will coagulate from absorbing the light energy as the blood has a large absorption coefficient in this wavelength range (see
As another example, LEDs with a central wavelength of about 570 nm (e.g., corresponding to the color red) are able to induce fresh blood cells to produce strong fluorescence in living tissue. Further, red LEDs may be useful in providing therapy for relatively deep tissue (e.g., about 1 mm to about 5 mm from the tissue surface, approximately equal to about 3 mm) as the light within such a wavelength range has a larger penetration depth than ultraviolet light, for instance.
As yet another example, LEDs with a central wavelength of about 650 nm are able to kill gangrene cells.
Light energy produced by therapeutic unit 1160 can also be absorbed by cells and enhance the immunity features of white blood cells, for example.
The present disclosure also relates to method of treating tissue using endoscope 1110. The method includes using the light source 1150 of endoscope 1110 to illuminate tissue, using the image sensor 1142 of endoscope 1110 to visualize tissue, and using the therapeutic unit 1160 of endoscope 1110 to treat tissue.
It will be understood that various modifications may be made to the embodiments described herein. Therefore, the above description should not be construed as limiting, but merely as exemplifications of various embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended thereto.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CN2017/078142 | 3/24/2017 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2018/170903 | 9/27/2018 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4584988 | Nishioka | Apr 1986 | A |
5377669 | Schulz | Jan 1995 | A |
5436655 | Hiyama | Jul 1995 | A |
5718663 | Wulfsberg | Feb 1998 | A |
5813987 | Modell | Sep 1998 | A |
6204523 | Carey et al. | Mar 2001 | B1 |
6260994 | Matsumoto et al. | Jul 2001 | B1 |
6331156 | Haefele et al. | Dec 2001 | B1 |
6449006 | Shipp | Sep 2002 | B1 |
6488619 | Miyanaga | Dec 2002 | B1 |
6503196 | Kehr et al. | Jan 2003 | B1 |
6533722 | Nakashima | Mar 2003 | B2 |
6569088 | Koshikawa | May 2003 | B2 |
6627333 | Hatwar | Sep 2003 | B2 |
6656112 | Miyanaga | Dec 2003 | B2 |
6696703 | Mueller-Mach et al. | Feb 2004 | B2 |
6796939 | Hirata et al. | Sep 2004 | B1 |
6821246 | Kasel et al. | Nov 2004 | B2 |
6918693 | Ota et al. | Jul 2005 | B2 |
6921920 | Kazakevich | Jul 2005 | B2 |
7119376 | Liu et al. | Oct 2006 | B1 |
7183577 | Mueller-Mach et al. | Feb 2007 | B2 |
7275931 | Katsuda et al. | Oct 2007 | B2 |
7413543 | Banik et al. | Aug 2008 | B2 |
7442167 | Dunki-Jacobs et al. | Oct 2008 | B2 |
7488088 | Brukilacchio | Feb 2009 | B2 |
7585273 | Adler et al. | Sep 2009 | B2 |
7635330 | Kang et al. | Dec 2009 | B2 |
7668450 | Todd et al. | Feb 2010 | B2 |
7691056 | Hirata | Apr 2010 | B2 |
7738940 | Shoji et al. | Jun 2010 | B2 |
7749160 | Hirata | Jul 2010 | B2 |
7931587 | Yoshino | Apr 2011 | B2 |
7968901 | Yamashita et al. | Jun 2011 | B2 |
7976459 | Laser | Jul 2011 | B2 |
8029439 | Todd et al. | Oct 2011 | B2 |
8043211 | Hirata | Oct 2011 | B2 |
8123680 | Kato et al. | Feb 2012 | B2 |
8211008 | Henzler | Jul 2012 | B2 |
8246230 | Todd et al. | Aug 2012 | B2 |
8400500 | Hirata | Mar 2013 | B2 |
8414480 | Kendale et al. | Apr 2013 | B2 |
8449457 | Aizenfeld et al. | May 2013 | B2 |
8480566 | Farr | Jul 2013 | B2 |
8485966 | Robertson | Jul 2013 | B2 |
8556806 | Farr | Oct 2013 | B2 |
8591408 | St. George et al. | Nov 2013 | B2 |
8622896 | Termanini | Jan 2014 | B1 |
8670028 | Takasaki | Mar 2014 | B2 |
8790253 | Sunagawa et al. | Jul 2014 | B2 |
8801255 | Kudo | Aug 2014 | B2 |
8878920 | Ovod | Nov 2014 | B2 |
9259140 | Hirosawa | Feb 2016 | B2 |
9270919 | Amling et al. | Feb 2016 | B2 |
9271630 | Amling et al. | Mar 2016 | B2 |
9271637 | Farr | Mar 2016 | B2 |
9277851 | Stuehle et al. | Mar 2016 | B2 |
9307893 | Kennedy, II et al. | Apr 2016 | B2 |
9319636 | King | Apr 2016 | B2 |
9357902 | Amling et al. | Jun 2016 | B2 |
9398839 | Rehe | Jul 2016 | B2 |
9408525 | Dahmen | Aug 2016 | B2 |
9498110 | Asatori | Nov 2016 | B2 |
9520428 | Fujimori | Dec 2016 | B2 |
9525852 | Wodnicki et al. | Dec 2016 | B2 |
9782059 | Saito et al. | Oct 2017 | B2 |
10111577 | Weber et al. | Oct 2018 | B2 |
10213097 | Kohno et al. | Feb 2019 | B2 |
10275905 | Yamaki | Apr 2019 | B2 |
10285577 | Czupalla et al. | May 2019 | B2 |
10708553 | Sonoda | Jul 2020 | B2 |
10952600 | Huang | Mar 2021 | B2 |
20020184122 | Yamaguchi et al. | Dec 2002 | A1 |
20050049462 | Kanazawa | Mar 2005 | A1 |
20050075538 | Banik et al. | Apr 2005 | A1 |
20050124858 | Matsuzawa | Jun 2005 | A1 |
20050203338 | Couvillon, Jr. | Sep 2005 | A1 |
20060215406 | Thrailkill | Sep 2006 | A1 |
20070173695 | Hirata | Jul 2007 | A1 |
20070197873 | Birnkrant | Aug 2007 | A1 |
20070225556 | Ortiz et al. | Sep 2007 | A1 |
20070249904 | Amano et al. | Oct 2007 | A1 |
20080045800 | Farr | Feb 2008 | A2 |
20080064925 | Gill | Mar 2008 | A1 |
20080077200 | Bendett | Mar 2008 | A1 |
20080119740 | Iddan | May 2008 | A1 |
20080158349 | Miller | Jul 2008 | A1 |
20080200758 | Orbay et al. | Aug 2008 | A1 |
20090058997 | Kato | Mar 2009 | A1 |
20090154192 | Krattiger | Jun 2009 | A1 |
20090247828 | Watanabe et al. | Oct 2009 | A1 |
20100188493 | Kanzaki et al. | Jul 2010 | A1 |
20100240953 | Murakami | Sep 2010 | A1 |
20100286475 | Robertson | Nov 2010 | A1 |
20100324632 | Lim | Dec 2010 | A1 |
20110009694 | Schultz et al. | Jan 2011 | A1 |
20110077465 | Mizuyoshi et al. | Mar 2011 | A1 |
20110092772 | Weber | Apr 2011 | A1 |
20110118547 | Erikawa | May 2011 | A1 |
20110184244 | Kagaya et al. | Jul 2011 | A1 |
20110263943 | Yamaguchi | Oct 2011 | A1 |
20120041267 | Benning | Feb 2012 | A1 |
20120071710 | Gazdzinski | Mar 2012 | A1 |
20120209072 | Oue et al. | Aug 2012 | A1 |
20120320581 | Rogers et al. | Dec 2012 | A1 |
20130131451 | Dillinger et al. | May 2013 | A1 |
20130265798 | Kudo | Oct 2013 | A1 |
20130285094 | Hsu et al. | Oct 2013 | A1 |
20130300847 | Hashimoto | Nov 2013 | A1 |
20130334577 | Ahn | Dec 2013 | A1 |
20140121468 | Eichenholz | May 2014 | A1 |
20140128745 | Willis | May 2014 | A1 |
20140316198 | Krivopisk et al. | Oct 2014 | A1 |
20140330081 | Imai | Nov 2014 | A1 |
20150094530 | Moriya | Apr 2015 | A1 |
20150202456 | Andersen | Jul 2015 | A1 |
20150222801 | Kresser | Aug 2015 | A1 |
20150272422 | Aoyama | Oct 2015 | A1 |
20150272442 | Motafakker-Fard et al. | Oct 2015 | A1 |
20150297069 | Coppersmith et al. | Oct 2015 | A1 |
20150366443 | Liolios | Dec 2015 | A1 |
20160007833 | Huang | Jan 2016 | A1 |
20160029879 | Ishikawa | Feb 2016 | A1 |
20160058277 | Selcho et al. | Mar 2016 | A1 |
20160073861 | Kaneko | Mar 2016 | A1 |
20160077008 | Takasu | Mar 2016 | A1 |
20160081533 | Couvillon, Jr. | Mar 2016 | A1 |
20160105606 | Hikita et al. | Apr 2016 | A1 |
20160106303 | Birnkrant et al. | Apr 2016 | A1 |
20160106306 | Furuta | Apr 2016 | A1 |
20160124211 | Wieters et al. | May 2016 | A1 |
20160166132 | Sasamoto et al. | Jun 2016 | A1 |
20160174823 | Asatori et al. | Jun 2016 | A1 |
20160210411 | Mentis | Jul 2016 | A1 |
20160213230 | Adair et al. | Jul 2016 | A1 |
20160217255 | Ukai et al. | Jul 2016 | A1 |
20160345814 | Sidar | Dec 2016 | A1 |
20160353983 | Onoe | Dec 2016 | A1 |
20170007095 | Kutsuma et al. | Jan 2017 | A1 |
20170035511 | Itoh et al. | Feb 2017 | A1 |
20170049312 | Seth | Feb 2017 | A1 |
20170150873 | Tatebayashi | Jun 2017 | A1 |
20170215714 | Shinji | Aug 2017 | A1 |
20180098686 | Tamiya | Apr 2018 | A1 |
20190150725 | Ramanujam | May 2019 | A1 |
20190216325 | Ouyang | Jul 2019 | A1 |
20190306467 | Sonoda | Oct 2019 | A1 |
20190388175 | Tatsuta | Dec 2019 | A1 |
20210100438 | Ding | Apr 2021 | A1 |
Number | Date | Country |
---|---|---|
1794944 | Jun 2006 | CN |
101874914 | Nov 2010 | CN |
102697449 | Oct 2012 | CN |
105249919 | Jan 2016 | CN |
106178279 | Dec 2016 | CN |
106308727 | Jan 2017 | CN |
1911389 | Apr 2008 | EP |
2353493 | Aug 2011 | EP |
2407087 | Jan 2012 | EP |
2008117184 | May 2008 | JP |
2010123858 | Oct 2010 | WO |
2014004992 | Jan 2014 | WO |
2014195843 | Dec 2014 | WO |
2016017325 | Feb 2016 | WO |
2016088512 | Jun 2016 | WO |
2016117373 | Jul 2016 | WO |
2018170903 | Sep 2018 | WO |
2018170904 | Sep 2018 | WO |
2019157763 | Aug 2019 | WO |
Entry |
---|
Machine English Translation of CN106178279A, Cong Wei; Liang Xudong; Liu Jinlin, Interposition-type ultraviolet light therapeutic instrument and control method thereof. |
Extended European Search Report dated Dec. 7, 2020 corresponding to counterpart Patent Application EP 17901503.7. |
International Search Report dated Dec. 27, 2017 and Written Opinion completed Dec. 21, 2017 corresponding to counterpart Int'l Patent Application PCT/CN2017/078142. |
Partial European Search Report corresponding to EP 15 17 6036.0 dated Nov. 25, 2015. |
Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 15 17 6036.0, dated May 6, 2016. |
European Office Action corresponding to counterpart Int'l Appln. No. EP 15 17 6036.0 dated Apr. 26, 2017. |
Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201510405306 dated Dec. 5, 2017. |
Chinese Second Office Action corresponding to counterpart Patent Application CN 201510405306 dated Jul. 31, 2018. |
Australian Examination Report No. 1 corresponding to counterpart Patent Application AU 2015203154 dated Mar. 13, 2019. |
Written Opinion completed Oct. 24, 2018 corresponding to Int'l Patent Application PCT/CN2018/076912. |
Chinese Office Action dated Dec. 2, 2020 corresponding to counterpart Patent Application CN 2020112702421630. |
Chinese Second Office Action dated Aug. 18, 2021 corresponding to counterpart Patent Application CN 201780088884.2. |
Chinese Third Office Action dated Feb. 18, 2022 corresponding to counterpart Patent Application CN 201780088884.2. |
Number | Date | Country | |
---|---|---|---|
20200016425 A1 | Jan 2020 | US |